Interestingly, current medications used to prevent AMS and reduce pulmonary vasopressor response, such as Sildenafil, Tdalafil, and Theophylline, are both PDE-5 inhibitors (Corbin et al., 2004). This evidence concerns the gene PDE5A and ablepharon macrostomia syndrome.